Skip to main content

Table 6 FNA performance per cytology group

From: The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes

Performance on Cytology Malignant (n = 24)

Genetic alteration

Histology malignant (n = 24)

Histology benign (n = 0)

Positive

14

0

Negative

10

0

  1. Sensitivity, 58 % (37–78); Specificity, NA% (NA); PPV, NA% (NA); NPV, NA% (NA), prevalence of malignant lesions, 100 %. Estimated performance when malignancy is prevalent at 95 %: PPV, NA% (NA); NPV, NA% (NA)
Back to article page

BMC Bioinformatics

ISSN: 1471-2105

Contact us